3957 POINT EDEN WAY, HAYWARD, CA
Achieves Enrollment Target in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation Treatment
Completes Enrollment in the PRECISE-BTN Clinical Study Evaluating the nPulse™ Vybrance™ Percutaneous Electrode System for Symptomatic Benign Thyroid Nodules
News, Underwriting Agreement, Legal Opinion
Reports Business Updates and Second Quarter 2026 Financial Results
Other Events, Press Release
Election of Seven Directors and Ratification of Deloitte Appointment
Announces Planned Redemption of Warrants
Q2
Q1
Amended Annual Report
FY 2024
Q3
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities to be Offered to Employees
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Submission Upload
Correspondence
Specialized Disclosure Report
Amended Schedule 13D - Ownership Report
Post-Effective Amendment to Registration Statement